Linda B. S. Aulin

Design principles of collateral sensitivity-based dosing strategies

Linda B. S. Aulin, Apostolos Liakopoulos, Piet H. van der Graaf et al. · Nature Communications · 2021 · 62 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

A multistate tuberculosis pharmacometric model: a framework for studying anti-tubercular drug effects<i>in vitro</i>

Oskar Clewe, Linda B. S. Aulin, Yanmin Hu et al. · Journal of Antimicrobial Chemotherapy · 2015 · 47 citations · Full text

Pharmacy, Pharmacology, Pharmacodynamics +15

Allele-specific collateral and fitness effects determine the dynamics of fluoroquinolone resistance evolution

Apostolos Liakopoulos, Linda B. S. Aulin, Matteo Buffoni et al. · Proceedings of the National Academy of Sciences · 2022 · 27 citations · Full text

Life Sciences, Evolutionary Biology, Microbiology +17

Population Pharmacokinetics of Unbound and Total Teicoplanin in Critically Ill Pediatric Patients

Linda B. S. Aulin, Peter De Paepe, Evelyn Dhont et al. · Clinical Pharmacokinetics · 2020 · 25 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +14

Evaluating the prevalence of Hepatitis E virus infection in a large cohort of European blood donors, 2015–2018

Katie Healy, Urban Freij, Marie Ellerstad et al. · Journal of Viral Hepatitis · 2022 · 18 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15